You are here
Strongbridge Biopharma plc to Host Fourth Quarter and Year-End 2018 Financial Results Conference Call on February 26, 2019
DUBLIN, Ireland and TREVOSE, Pa., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that it will host a conference call with members of Strongbridge’s management team on Tuesday, February 26 at 8:30 a.m. ET to discuss the Company’s fourth quarter and year-end 2018 financial results and corporate highlights. The conference call will follow the anticipated release of the Company’s financial results earlier that day.
Tuesday, February 19, 2019 - 07:30